The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of antiresorptive therapies in improving patient care in early and metastatic breast cancer
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 132, Issue 2, Pages 355-363
Publisher
Springer Nature
Online
2011-10-10
DOI
10.1007/s10549-011-1800-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
- (2011) C.L. Shapiro et al. EUROPEAN JOURNAL OF CANCER
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
- (2010) H L Neville-Webbe et al. BRITISH JOURNAL OF CANCER
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Bisphosphonates for osteoporosis treatment are associated with reduced breast cancer risk
- (2010) P A Newcomb et al. BRITISH JOURNAL OF CANCER
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer
- (2010) Mohamed S. Zaghloul et al. International Journal of Clinical Oncology
- Prevention of Aromatase Inhibitor–Induced Bone Loss Using Risedronate: The SABRE Trial
- (2010) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
- (2010) Rowan T. Chlebowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Use of Bisphosphonates and Risk of Postmenopausal Breast Cancer
- (2010) Gad Rennert et al. JOURNAL OF CLINICAL ONCOLOGY
- Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
- (2010) Alison T. Stopeck et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
- (2009) Stephanie L. Hines et al. BREAST CANCER RESEARCH AND TREATMENT
- Osteonecrosis of the jaw and use of bisphosphonates in adjuvant breast cancer treatment: a metanalysis
- (2009) Davide Mauri et al. BREAST CANCER RESEARCH AND TREATMENT
- Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
- (2009) Adam M. Brufsky et al. Clinical Breast Cancer
- Giant cell tumour of bone
- (2009) David M Thomas et al. CURRENT OPINION IN ONCOLOGY
- Efficacy and Safety of Denosumab in Postmenopausal Women with Osteopenia or Osteoporosis: A Systematic Review and a Meta-analysis
- (2009) A. D. Anastasilakis et al. HORMONE AND METABOLIC RESEARCH
- The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis
- (2009) Kostantinos Zarogoulidis et al. INTERNATIONAL JOURNAL OF CANCER
- Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment
- (2009) Dawn L. Hershman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant oral clodronate improves the overall survival of primary breast cancer patients with micrometastases to the bone marrow--a long-term follow-up
- (2008) I. J. Diel et al. ANNALS OF ONCOLOGY
- Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan
- (2008) C. I. Ripamonti et al. ANNALS OF ONCOLOGY
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial
- (2008) Paul D. Miller et al. BONE
- Exploring the anti-tumour activity of bisphosphonates in early breast cancer
- (2008) M.C. Winter et al. CANCER TREATMENT REVIEWS
- Prevention of Anastrozole-Induced Bone Loss with Monthly Oral Ibandronate during Adjuvant Aromatase Inhibitor Therapy for Breast Cancer
- (2008) J. E. Lester et al. CLINICAL CANCER RESEARCH
- Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
- (2008) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Frequency and Risk Factors Associated With Osteonecrosis of the Jaw in Cancer Patients Treated With Intravenous Bisphosphonates
- (2008) Ana O Hoff et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Randomized Trial of Denosumab in Patients Receiving Adjuvant Aromatase Inhibitors for Nonmetastatic Breast Cancer
- (2008) Georgiana K. Ellis et al. JOURNAL OF CLINICAL ONCOLOGY
- Risedronate Prevents Bone Loss in Breast Cancer Survivors: A 2-Year, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
- (2008) Susan L. Greenspan et al. JOURNAL OF CLINICAL ONCOLOGY
- Zoledronic Acid Prevents Bone Loss in Premenopausal Women Undergoing Adjuvant Chemotherapy for Early-Stage Breast Cancer
- (2008) Dawn L. Hershman et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Anastrozole on Bone Mineral Density: 5-Year Results From the Anastrozole, Tamoxifen, Alone or in Combination Trial 18233230
- (2008) Richard Eastell et al. JOURNAL OF CLINICAL ONCOLOGY
- Natural History of Osteonecrosis of the Jaw in Patients With Multiple Myeloma
- (2008) Ashraf Badros et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer
- (2008) Stephanie L. Hines et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
- New research findings on zoledronic acid: Survival, pain, and anti-tumour effects
- (2007) Fred Saad CANCER TREATMENT REVIEWS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now